Djillali Annane
Distinguished in Limb-Girdle Muscular Dystrophy Type 2C

Djillali Annane

Garches, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Limb-Girdle Muscular Dystrophy Type 2C
Garches, FR 
OverviewLocationsClinical Research

Overview

Djillali Annane practices in Garches, France. Mr. Annane is rated as a Distinguished expert by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2C. His top areas of expertise are Sepsis, COVID-19, Acute Respiratory Distress Syndrome (ARDS), Hepato-Pancreato-Biliary Surgery, and Thrombectomy.

His clinical research consists of co-authoring 396 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Limb-Girdle Muscular Dystrophy Type 2C.

Gender
Male

Locations

Garches, France
Other Locations
Villejuif, France
Versailles, France
Montigny-sur-loing, 78180, France
Paris, France
Creteil, France
Boulogne-billancourt, 92100, France
Saint-aubin-les-forges, France
Nimes, France
Besancon, France
104. Boulevard Raymond Poincaré, Garches, 92380, Irles, France
Raymond, 92380, France
Saint-quentin-le-verger, France
INSERM U1173, University Of Versailles St Quentin, INSERM U1028, CNRS UMR5292, Lyon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined Morbidity-mortality Endpoint in Patients With Cardiogenic Shock
Enrollment Status: Recruiting
Publish Date: August 05, 2025
Intervention Type: Drug
Study Drug: Levosimendan
Study Phase: Phase 3
Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Enrollment Status: Unknown
Publish Date: August 31, 2023
Intervention Type: Drug
Study Drug: Esmolol
Study Phase: Phase 2
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
Enrollment Status: Terminated
Publish Date: February 06, 2023
Intervention Type: Drug
Study Phase: Phase 2
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Effects of Low-dose Corticosteroids on Survival of Severe Community-acquired Pneumonia
Enrollment Status: Completed
Publish Date: January 10, 2023
Intervention Type: Drug
Study Drug: Hydrocortisone
Study Phase: Phase 3
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Value of Early Treatment With Polyvalent Immunoglobulin in the Management of Acute Respiratory Distress Syndrome Associated With SARS-CoV-2 Infections
Enrollment Status: Completed
Publish Date: August 19, 2021
Intervention Type: Drug
Study Drug: Human Immunoglobulin
Study Phase: Phase 3
Cough Determinants in Mechanically Ventilated Patients: a Physiological Study
Cough Determinants in Mechanically Ventilated Patients: a Physiological Study
Enrollment Status: Completed
Publish Date: April 22, 2019
Intervention Type: Other
Study Phase: Not Applicable
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Impact on Mortality of the Timing of Renal Replacement Therapy in Patients With Severe Acute Kidney Injury in Septic Shock: the IDEAL-ICU Study (Initiation of Dialysis Early Versus Delayed in the Intensive Care Unit): Study Protocol for a Randomized Controlled Trial
Enrollment Status: Terminated
Publish Date: November 27, 2018
Intervention Type: Procedure
Study Phase: Phase 3
View 6 Less Clinical Trials

395 Total Publications

French guidelines on sepsis: A pragmatic frame to manage septic patients.
French guidelines on sepsis: A pragmatic frame to manage septic patients.
Journal: Anaesthesia, critical care & pain medicine
Published: October 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Annane's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 11 Advanced Conditions
View All 27 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile